Ledger.Open graph →
SEC Form D · filed August 12, 2024

Linus Biotechnology Inc

Offering
$10.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
North Brunswick, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Rafi Syed · Menlo Park, CADirectorAmol Deshpande · Waltham, MADirectorAshok Krishnamurthi · San Mateo, CADirectorManish Arora · New Rochelle, NYExec · DirectorRafi Syed · Menlo Park, CADirectorAmol Deshpande · San Mateo, CADirectorAshok Krishnamurthi · Philadelphia, PADirectorManish Arora · New Rochelle, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗